We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARTNA icon
5251
Artesian Resources
ARTNA
$358M
-411
Closed -$13.4K
ASTI icon
5252
Ascent Solar Technologies
ASTI
$35.1M
-1,237
Closed -$1.74K
ATGL
5253
Alpha Technology Group
ATGL
$137M
-7
Closed -$189
ATRA icon
5254
Atara Biotherapeutics
ATRA
$76.1M
-185
Closed -$1.1K
AUBN icon
5255
Auburn National Bancorp
AUBN
$91.9M
-18
Closed -$389
AWF
5256
AllianceBernstein Global High Income Fund
AWF
$872M
-629
Closed -$6.75K
AXDX
5257
DELISTED
Accelerate Diagnostics
AXDX
-2,930
Closed -$2.05K
AXR icon
5258
AMREP Corp
AXR
$119M
-405
Closed -$8.12K
BBU
5259
DELISTED
Brookfield Business Partners
BBU
-2,207
Closed -$51.8K
BCLI
5260
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-135
Closed -$170
BCTX
5261
Briacell Therapeutics
BCTX
$31.7M
-1
Closed -$37
BFIN
5262
DELISTED
BankFinancial
BFIN
-599
Closed -$7.57K
BGR icon
5263
BlackRock Energy and Resources Trust
BGR
$405M
-196
Closed -$2.66K
BGY icon
5264
BlackRock Enhanced International Dividend Trust
BGY
$529M
-4
Closed -$22
BHAT
5265
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
-7
Closed -$652
BLDP
5266
Ballard Power Systems
BLDP
$790M
-9,934
Closed -$10.9K
BLTE
5267
Belite Bio
BLTE
$6.54B
-14
Closed -$927
BLUE
5268
DELISTED
bluebird bio
BLUE
-2,421
Closed -$11.8K
BNDX icon
5269
Vanguard Total International Bond ETF
BNDX
$83.1B
-42
Closed -$2.05K
BOE icon
5270
BlackRock Enhanced Global Dividend Trust
BOE
$684M
-6
Closed -$65
BOND icon
5271
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.49B
-13
Closed -$1.2K
BRDG
5272
DELISTED
Bridge Investment Group
BRDG
-1,100
Closed -$10.5K
BSET icon
5273
Bassett Furniture
BSET
$176M
-272
Closed -$4.15K
BTAL icon
5274
AGF US Market Neutral Anti-Beta Fund
BTAL
$300M
-480
Closed -$10K
SLAI
5275
DELISTED
SOLAI Ltd ADS
SLAI
-3
Closed -$33

Similar funds

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.